B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
- Signal Transduct Target Ther. 2023 Oct 20;8(1):389. doi: 10.1038/s41392-023-01643-w.
Affiliations
- 1. Department of Thoracic Surgery, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China.
- 2. Lung Transplant Research Laboratory, Institute of Thoracic Oncology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China.
- 3. Department of Thoracic Surgery, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China. [email protected].
- 4. Lung Transplant Research Laboratory, Institute of Thoracic Oncology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China. [email protected].
PMID: 37857611
DOI: 10.1038/s41392-023-01643-w
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Transmembrane Glycoprotein